国际药物开发与研究杂志

  • 国际标准期刊号: 0975-9344
  • 期刊 h 指数: 44
  • 期刊引用分数: 59.93
  • 期刊影响因子: 48.80
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Therapy Compliance in Hypertension: Indian Clinicians’ Viewpoint

Dave Nilanj S, Sharma Ramandeep T, Kulkarni Girish R and Sen Sankar

Context: Poor compliance to antihypertensive therapies has been linked to a variety of problems, including poor blood pressure control, rehospitalisation, and increased healthcare resource utilization.

Setting and Design: Considering this, a cross-sectional survey of health care physicians (HCPs) treating hypertension from government or private practice across the India was conducted.

Aims: The purpose of the survey was to capture clinician viewpoint on the therapy compliance in the management of hypertension.

Methods and Materials: This was a paper-based survey where all HCPs were asked to respond to survey questionnaire during a personal meeting with the study interviewer.

Results: Total 2746 clinicians from more than 150 cities across the India were involved in this survey. Approximately 69% of clinicians believed that more than 1/4th of patients are not controlled for their hypertension. Out of all responders, 93.5% expressed that non-compliance to the medicine is one of the major reasons for the uncontrolled hypertension. Around 94% of responders expressed that patient compliance program can improve the compliance to the medicine in hypertension management.

Conclusions: Indian clinicians feel that uncontrolled hypertension is still be a widely prevalent problem in spite of availability of effective antihypertensive drugs and non-compliance to the medication is one of the major modifiable risk factor for this.